F. LaFerla

Physiology · 2002–2019

A researcher in the Science corpus: 11 papers; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 116 citations into it; #769 of 2,276 by trust here, #525 by citations
• Molecular Biology — 90 citations into it; #8,373 of 17,773 by trust here, #5,764 by citations
• Pharmacology — 25 citations into it
• Computational Theory and Mathematics — 11 citations into it

Whom F. LaFerla trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Selkoe
2. S. Oddo
3. M. Murphy
4. T. Wyss‐Coray

Who trusts F. LaFerla overall

1. Alexei Verkhratsky
2. Richard O'Brien
3. Ralph A. Nixon
4. P. Reddy
5. M. Mańczak
6. M. Calkins
7. D. Lindholm
8. K. Barnham
9. E. Tönnies
10. S. Doronkin

Papers from F. LaFerla's perspective

Ordered by how strongly the researchers F. LaFerla trusts endorse each paper. Same corpus, a different order for every researcher.

1. Alzheimer's disease: genes, proteins, and therapy. (Physiological Reviews)
2. Intraneuronal Aβ42 Accumulation in Human Brain
3. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 (Nature)
4. Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease (Journal of Neuroscience)
5. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing (Nature)
6. Neurotoxicity induces cleavage of p35 to p25 by calpain (Nature)
7. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. (Neuron)
8. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. (Journal of the American Medical Association (JAMA))
9. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. (Archives of Neurology)
10. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity (Nature)

Their papers

• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease (2005) — 671 citations
• Intracellular amyloid-β in Alzheimer's disease (2007) — 1,783 citations
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease (2002) — 1,022 citations
• A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP (2002) — 257 citations
• Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. (2003) — 1,020 citations
• Alzheimer's disease. (2010) — 1,307 citations
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease (2009) — 862 citations
• Intracellular amyloid-beta in Alzheimer's disease. (2007) — 838 citations
• Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease (2006) — 643 citations
• Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice (2005) — 1,314 citations